Skip to main content
. 2021 May 28;9:676156. doi: 10.3389/fcell.2021.676156

FIGURE 9.

FIGURE 9

The dysregulation of hub genes was correlated to the survival time in patients with esophageal adenocarcinoma (EA) and esophageal squamous cell carcinoma (ESCC). (A,B) Higher expression levels of MAPK1 were associated with longer overall survival (OS) time in patients with ESCC, not EA. (C,D) Higher expression levels of ACOX1 were associated with shorter OS time in patients with ESCC and longer OS time in patients with EA. (E,F) Higher expression levels of SCP2 were associated with shorter OS time in patients with ESCC, but not EA. (G,H) Higher expression levels of NLN were associated with shorter OS time in patients with EA, but not ESCC.